Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3' untranslated region of dengue virus type-2 RNA

Autor: Julie K. Calvert, Jennifer N. Clarke, Jillian M. Carr, Stuart M. Pitson, T. Kua, Michael R. Beard, Julia R. Zebol

This item is under embargo for a period of 12 months from the date of publication, in accordance with the publisher's policy.
Sphingosine kinase 1 (SphK1) is a lipid kinase with important roles including regulation of cell survival. We have prev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07e6bf6ff044ed3a4ac84c3078a8d96
https://hdl.handle.net/1959.8/153046

Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.

Autor: Neubauer HA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia., Tea MN; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Zebol JR; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Gliddon BL; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Stefanidis C; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia., Moretti PAB; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Pitman MR; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Costabile M; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia., Kular J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Stringer BW; QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Day BW; QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Samuel MS; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Bonder CS; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Powell JA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Pitson SM; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia. stuart.pitson@unisa.edu.au.; School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia. stuart.pitson@unisa.edu.au.; Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia. stuart.pitson@unisa.edu.au.

Publikováno v: Oncogene [Oncogene] 2019 Feb; Vol. 38 (8), pp. 1151-1165. Date of Electronic Publication: 2018 Sep 24.

An oncogenic role for sphingosine kinase 2.

Autor: Neubauer HA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia., Pham DH; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia., Zebol JR; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Moretti PA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Peterson AL; Monash Institute of Pharmaceutical Science, Monash University, Parkville, Victoria, Australia., Leclercq TM; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Chan H; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia., Powell JA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia., Pitman MR; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Samuel MS; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia., Bonder CS; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia., Creek DJ; Monash Institute of Pharmaceutical Science, Monash University, Parkville, Victoria, Australia., Gliddon BL; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Pitson SM; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.

Publikováno v: Oncotarget [Oncotarget] 2016 Oct 04; Vol. 7 (40), pp. 64886-64899.